Innate immunity probed by lipopolysaccharides affinity strategy and proteomics

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 2-3, 2013, Pages 775-784

  Giangrande, Chiara ^a   Colarusso, Lucia ^a   Lanzetta, Rosa ^a   Molinaro, Antonio ^a   Pucci, Piero ^a   Amoresano, Angela ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Affinity; Innate immunity; Lipopolysaccharide; Proteomics

Indexed keywords

BACTERIA; CELL MEMBRANES; ELECTROPHORESIS; MASS SPECTROMETRY; POLYSACCHARIDES; PROTEINS; PROTEOMICS;

AFFINITY; ALPHA 2-MACROGLOBULIN; BIOLOGICAL MECHANISMS; GRAM-NEGATIVE BACTERIA; INNATE IMMUNITY; LIPOPOLYSACCHARIDES; MICROBIAL STRUCTURES; PATHOGEN-ASSOCIATED MOLECULAR PATTERNS;

IMMUNE SYSTEM;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 84873745319     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6204-3     Document Type: Article

References (39)

1. BA Beutler 2009 TLRs and innate immunity Blood 113 1399 1407 10.1182/blood-2008-07-019307 1:CAS:528:DC%2BD1MXitlCrt7g%3D
2. R Medzhitov C Janeway Jr 2000 Innate Immunity N Engl J Med 343 338 344 10.1056/NEJM200008033430506 1:CAS:528:DC%2BD3cXlvVOltbs%3D
3. A Iwasaki R Medzhitov 2004 Toll-like receptor control of the adaptive immune responses Nat Immunol 5 987 995 10.1038/ni1112 1:CAS:528: DC%2BD2cXnvFCgsrg%3D
4. S Akira S Uematsu O Takeuchi 2006 Pathogen recognition and innate immunity Cell 124 783 801 10.1016/j.cell.2006.02.015 1:CAS:528: DC%2BD28Xit1Kltb8%3D
5. SI Miller RK Ernst MW Bader 2005 LPS, TLR4 and infectious disease diversity Nat Rev Microbiol 3 36 46 10.1038/nrmicro1068 1:CAS:528: DC%2BD2cXhtVyqtrbN
6. GL Su RL Simmons SC Wang 1995 Lipopolysaccharide binding protein participation in cellular activation by LPS Crit Rev Immunol 15 201 214 10.1615/CritRevImmunol.v15.i3-4.10 1:CAS:528:DyaK28Xhs1yhu7c%3D
7. MM Wurfel ST Kunitake H Lichenstein JP Kane SD Wright 1994 Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS J Exp Med 180 1025 1035 10.1084/jem.180.3.1025 1:CAS:528:DyaK2cXlsFGks7k%3D
8. ZQ Wang WM Xing HH Fan KS Wang HK Zhang QW Wang J Qi HM Yang J Yang YN Ren SJ Cui X Zhang F Liu DH Lin WH Wang MK Hoffmann ZG Han 2009 The novel lipopolysaccharide-binding protein CRISPLD2 is a critical serum protein to regulate endotoxin function J Immunol 183 6646 6656 10.4049/jimmunol.0802348 1:CAS:528:DC%2BD1MXhtlKhtr%2FL
9. T Nakamura F Tokunaga T Morita S Iwanaga 1988 Interaction between lipopolysaccharide and intracellular serine protease zymogen, factor C, from horseshoe crab (Tachypleus tridentatus) hemocytes J Biochem 103 370 374 1:CAS:528:DyaL1cXht1OnurY%3D
10. NS Tan B Ho JL Ding 2000 High-affinity LPS binding domain(s) in recombinant factor C of a horseshoe crab neutralizes LPS-induced lethality FASEB J 14 859 870 10.1096/fj.99-0866com 1:CAS:528:DC%2BD3cXjtVejtbs%3D
11. Z Xu CX Huang Y Li PZ Wang GL Ren CS Chen FJ Shang Y Zhang QQ Liu ZS Jia QH Nie YT Sun XF Bai 2007 Toll-like receptor 4 siRNA attenuates LPS-induced secretion of inflammatory cytokines and chemokines by macrophages J Infect 55 e1 e9 10.1016/j.jinf.2007.01.003
12. L Guillot S Medjane K Le-Barillec V Balloy C Danel M Chignard M Si-Tahar 2004 Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4 Biol Chem 279 2712 2718 1:CAS:528:DC%2BD2cXkslOqug%3D%3D
13. A Poltorak P Ricciardi-Castagnoli S Citterio B Beutler 2000 Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation Proc Natl Acad Sci U S A 97 2163 2167 10.1073/pnas.040565397 1:CAS:528:DC%2BD3cXhslKhtrY%3D
14. U Ohto K Fukase K Miyake Y Satow 2007 Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa Science 316 1632 1634 10.1126/science.1139111 1:CAS:528:DC%2BD2sXmtl2jsLY%3D
15. J Andrä T Gutsmann M Müller AB Schromm 2010 Interactions between lipid A and serum proteins Adv Exp Med Biol 667 39 51 10.1007/978-1-4419-1603-7-4
16. JC Marshall 2005 Lipopolysaccharide: an endotoxin or an exogenous hormone? Clin Infect Dis 41 S470 S480 10.1086/432000 1:CAS:528: DC%2BD2MXht1emu7bO
17. TH Mogensen 2009 Pathogen recognition and inflammatory signaling in innate immune defenses Clin Microbiol Rev 22 240 273 10.1128/CMR.00046-08 1:CAS:528:DC%2BD1MXmtVSqt7k%3D
18. WJ Liaw C Tzao JY Wu SJ Chen JH Wang CC Wu 2003 Inhibition by terbutaline of nitric oxide and superoxide anion levels of endotoxin-induced organs injury in the anesthetized rat Shock 19 281 288 10.1097/00024382-200303000-00014 1:CAS:528:DC%2BD2cXivFGrsr8%3D
19. RK Kollipara NB Perumal 2010 LPS-stimulated pro-inflammatory vs. antibacterial macrophage genes Immunome Res 6 5 10.1186/1745-7580-6-5
20. M Matsumoto Y Horiuchi A Yamamoto M Ochiai M Niwa T Takagi H Omi T Kobayashi MM Suzuki 2010 Lipopolysaccaride-binding peptides obtained by phage display method J Microbiol Methods 82 54 58 10.1016/j.mimet.2010.04.002 1:CAS:528:DC%2BC3cXntFSgsbs%3D
21. WJ Qian JM Jacobs DG Camp ME Monroe RJ Moore MA Gritsenko SE Calvano SF Lowry W Xiao LL Moldawer RW Davis RG Tompkins RD Smith 2005 Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry Proteomics 5 572 584 10.1002/pmic.200400942 1:CAS:528:DC%2BD2MXhs1Oiurs%3D
22. S Li L Wang M Berman YY Kong ME Dorf 2011 Mapping a dynamic innate immunity protein interaction network regulating type I interferon production Immunity 35 426 440 10.1016/j.immuni.2011.06.014 1:CAS:528:DC%2BC3MXht1WmurjN
23. O Westphal K Jann 1965 Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure Methods Carbohydr Chem 5 83 91 1:CAS:528:DyaF2MXktFSgtLY%3D
24. C De Castro M Parrilli O Holst A Molinaro 2010 Microbe-associated molecular patterns in innate immunity: Extraction and chemical analysis of gram-negative bacterial lipopolysaccharides Methods Enzymol 480 89 115 10.1016/S0076-6879(10)80005-9
25. M Monti M Cozzolino F Cozzolino R Tedesco P Pucci 2007 Functional proteomics: protein-protein interactions in vivo Ital J Biochem 56 310 314
26. L Deban S Jaillon C Garlanda B Bottazzi A Mantovani 2010 Pentraxins in innate immunity: lessons from PTX3 Cell Tissue Res 343 237 249 10.1007/s00441-010-1018-0
27. YG Kim YH Yang BG Kim 2010 High-throughput characterization of lipopolysaccharide-binding proteins using mass spectrometry J Chromatogr B Anal Technol Biomed Life Sci 878 3323 3326 10.1016/j.jchromb.2010.10.001 1:CAS:528:DC%2BC3cXhsVGrtrnM
28. Triantafilou M, Mouratis MA, Lepper P, Haston RM, Baldwin F, Lowes S, Ahmed MA, Schumann C, Boyd O, Triantafilou K (2012) Serum proteins modulate lipopolysaccharide and lipoteichoic acid-induced activation and contribute to the clinical outcome of sepsis. Virulence 2:1-3
29. MA Oliver JM Rojo S Rodríguez de Córdoba S Alberti 2008 Binding of complement regulatory proteins to group A Streptococcus Vaccine 26 Suppl 8 I75 I78 10.1016/j.vaccine.2008.11.054 1:CAS:528:DC%2BD1cXhsFajsrvJ
30. H Amdahl H Jarva M Haanperä J Mertsola Q He TS Jokiranta S Meri 2011 Interactions between Bordetella pertussis and the complement inhibitor factor H Mol Immunol 48 697 705 10.1016/j.molimm.2010.11.015 1:CAS:528:DC%2BC3MXjsFSk
31. G Ambrus P Gál M Kojima K Szilágyi J Balczer J Antal L Gráf A Laich BE Moffatt W Schwaeble RB Sim P Závodszky 2003 Natural substrates and inhibitors of mannan-binding le ctin-associated serine protease-1 and -2: a study on recombinant catalytic fragments J Immunol 170 1374 1382 1:CAS:528:DC%2BD3sXnvVOksg%3D%3D
32. S Gulati K Sastry JC Jensenius PA Rice S Ram 2002 Regulation of the mannan-binding lectin pathway of complement on Neisseria gonorrhoeae by C1-inhibitor and alpha 2-macroglobulin J Immunol 168 4078 4086 1:CAS:528:DC%2BD38XivV2isLs%3D
33. VP Ferreira MK Pangburn C Cortés 2010 Complement control protein factor H: the good, the bad, and the inadequate Mol Immunol 47 2187 2197 10.1016/j.molimm.2010.05.007 1:CAS:528:DC%2BC3cXpslSqsL8%3D
34. LA Tan B Yu FC Sim U Kishore RB Sim 2010 Complement activation by phospholipids: the interplay of factor H and C1q Protein Cell 1 1033 1049 10.1007/s13238-010-0125-8 1:CAS:528:DC%2BC3cXhsFCgsb%2FK
35. LA Tan AC Yang U Kishore RB Sim 2011 Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway Protein Cell 2 320 332 10.1007/s13238-011-1029-y 1:CAS:528:DC%2BC3MXmtVyktLY%3D
36. GA Manderson M Martin P Onnerfjord T Saxne A Schmidtchen TE Mollnes D Heinegård AM Blom 2009 Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system Mol Immunol 46 3388 3398 10.1016/j.molimm.2009.07.011 1:CAS:528:DC%2BD1MXht1Whtb%2FP
37. O Shannon V Rydengård A Schmidtchen M Mörgelin P Alm OE Sørensen L Björck 2010 Histidine-rich glycoprotein promotes bacterial entrapment in clots and decreases mortality in a mouse model of sepsis Blood 116 2365 2372 10.1182/blood-2010-02-271858 1:CAS:528:DC%2BC3cXhtlWrtLjN
38. MF Henning V Herlax L Bakás 2011 Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect Innate Immun 17 327 337 10.1177/1753425910370709 1:CAS:528: DC%2BC3MXptleguro%3D
39. Y Li JB Dong MP Wu 2008 Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice Eur J Pharmacol 590 417 422 10.1016/j.ejphar.2008.06.047 1:CAS:528: DC%2BD1cXpt1Knurw%3D